Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images

BACKGROUND: Epidermal growth factor receptor (EGFR) genotyping and programmed death ligand-1 (PD-L1) expressions are of paramount importance for treatment guidelines such as the use of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) in lung cancer. Conventional identificati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chengdi, Ma, Jiechao, Shao, Jun, Zhang, Shu, Liu, Zhongnan, Yu, Yizhou, Li, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895233/
https://www.ncbi.nlm.nih.gov/pubmed/35250988
http://dx.doi.org/10.3389/fimmu.2022.813072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895233/
https://www.ncbi.nlm.nih.gov/pubmed/35250988
http://dx.doi.org/10.3389/fimmu.2022.813072

Ejemplares similares